Huntsman vs Ingevity
HUN and NGVT side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HUN and NGVT compare
Ingevity is the larger company, worth 1.3 times as much as Huntsman ($2.1B against $1.7B).
Huntsman grew revenue faster over the last twelve months (0.65% versus −3.7% for Ingevity).
Ingevity keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with −3.1% at Huntsman.
Huntsman pays a dividend yielding 3.7%; Ingevity does not pay one.
Ingevity scores higher on the StockData Score (6 against 3 for Huntsman), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HUN | NGVT |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $2.1B |
| Share price | $9.53 | $61.72 |
| Change, 1 year | 12.4% | 25.6% |
| Change, 5 years | −70.4% | −21.7% |
| Beta (5Y) | 0.85 | 1.21 |
| Employees | 6,000 | 1,500 |
| StockData Score | ||
| Total score | 3 | 6 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 1 (better) | 0 |
| Valuation | ||
| P/E | – | 36.3× |
| P/S | 0.3× (better) | 1.9× |
| P/B | 0.6× (better) | 33.7× |
| EV/EBITDA | 13.8× (better) | 23.1× |
| P/FCF | – | 17.3× |
| FCF yield | −0.54% | 5.8% (better) |
| Fair value | $8.15 | $35.71 |
| Margin of safety | −16.9% (better) | −72.8% |
| Growth | ||
| Revenue growth (TTM) | 0.65% (better) | −3.7% |
| Revenue growth, 5Y average | 0.95% (better) | −0.81% |
| Profitability | ||
| Gross margin | 13.5% | 42.0% (better) |
| Operating margin | −0.54% | – |
| Net margin | −3.1% | 5.3% (better) |
| FCF margin | −0.15% | 10.8% (better) |
| Return on equity | −6.5% | 59.5% (better) |
| Return on invested capital | −0.57% | – |
| Financial health | ||
| Debt / equity | 0.78 (better) | 18.18 |
| Net debt / EBITDA | 6.59 (better) | 7.68 |
| Current ratio | 1.33 | 1.48 (better) |
| Altman Z-score | 1.47 | 2.29 (better) |
| Piotroski F-score | 2 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.7% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 5.2% | – |
| Buyback yield | – | 7.4% |
| Shareholder yield | 3.7% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 88.7% | 102% |
| Held by insiders | 6.7% | 1.4% |
| Insider net buying, 12 months | $981K (better) | −$1.8M |
| Short interest, % of float | 7.4% | 3.7% |
Go deeper
- HUN stock overview
- HUN income statement
- HUN valuation and score
- NGVT stock overview
- NGVT income statement
- NGVT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.